Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Circulating Multiple Myeloma Cells (CMMCs): A Novel Method for Detection and Molecular Characterization of Peripheral Blood Plasma Cells in Multiple Myeloma Precursor States

Brendan Weiss, Kate Sasser, Chandra Rao, Brad Foulk, Steven Gross, Gayle Mallon, Colleen Erb, Anne Berkowitz, Patricia A. Mangan, Brenda K. Shelly, Adam D. Cohen, MD, Dan T. Vogl, Alfred L. Garfall, MD, Edward A. Stadtmauer

Blood (2014) 124 (21): 2031.

https://doi.org/10.1182/blood.V124.21.2031.2031

Published: 2014

Journal Articles

A Single-Center Retrospective Comparison of Post-Transplant Outcomes in Patients Receiving VRD Vs. VD Vs. RD As Initial Therapy Prior to ASCT for Newly Diagnosed Multiple Myeloma (MM)

Nathan C Nussbaum, MD, Andrew Dougherty, Dan T. Vogl, MD, MSCE, Brendan M Weiss, MD, David L Porter, MD, E Paul Wileyto, Kathleen Cunningham, Patricia A. Mangan, Brenda K. Shelly, Heather DiFilippo, Edward A. Stadtmauer, MD

Blood (2012) 120 (21): 2042.

https://doi.org/10.1182/blood.V120.21.2042.2042

Published: 2012

Journal Articles

Combined Autophagy and Proteasome Inhibition for Multiple Myeloma: Final Results of a Phase 1 Trial of Hydroxychloroquine and Standard Dose Bortezomib for Patients with Relapsed or Refractory Myeloma

Dan T. Vogl, MD, MSCE, Edward A. Stadtmauer, MD, James Bradner, MD, Lisa Davis, PharmD, Thomas M. Paul, Emma C. Scott, MD, Charles W. Nichols, MD, David L. Porter, MD, Martin Carroll, MD, Janeen Kaplan, Gayle Mallon, Cezary R. Swider, Patricia A. Mangan, Brenda K. Shelly, Ravi K. Amaravadi, MD

Blood (2011) 118 (21): 1869.

https://doi.org/10.1182/blood.V118.21.1869.1869

Published: 2011

Journal Articles

Transfer of influenza vaccine–primed costimulated autologous T cells after stem cell transplantation for multiple myeloma leads to reconstitution of influenza immunity: results of a randomized clinical trial

Edward A. Stadtmauer, Dan T. Vogl, Eline Luning Prak, Jean Boyer, Nicole A. Aqui, Aaron P. Rapoport, Kenyetta R. McDonald, Xiaoling Hou, Heather Murphy, Rita Bhagat, Patricia A. Mangan, Anne Chew, Elizabeth A. Veloso, Bruce L. Levine, Robert H. Vonderheide, Abbas F. Jawad, Carl H. June, Kathleen E. Sullivan

Blood (2011) 117 (1): 63–71.

https://doi.org/10.1182/blood-2010-07-296822

Published: 2011

Journal Articles

Influenza (flu) Vaccine Administration to Patients with Multiple Myeloma (MM) Prior to Autologous T-Cell Harvest Leads to Better Reconstitution of Flu Immunity After High Dose Melphalan and Autologous Stem Cell Transplant (ASCT) and Reinfusion of Primed Ex-Vivo Co-Stimulated Autologous T-Cells and Post-ASCT Second Flu Vaccination Than Post-ASCT Flu Vaccination Alone.

Edward A. Stadtmauer, MD, Dan T. Vogl, MD, Nicole A. Aqui, MD, Aaron P. Rapoport, MD, Kenyetta Macdonald, Heather Murphy, Rita Bhagat, RN, Patricia A. Mangan, APRN, BC, Anne Chew, PhD, Elizabeth Veloso, RN, JD, Bruce Levine, PhD, Robert H. Vonderheide, MD, DPhil, Carl H. June, MD, Kathleen Sullivan, MD

Blood (2009) 114 (22): 797.

https://doi.org/10.1182/blood.V114.22.797.797

Published: 2009

Journal Articles

Plerixafor and G-CSF Versus Cyclophosphamide and G-CSF for Stem Cell Mobilization in Patients with Multiple Myeloma.

Aziz Nazha, MD, Rachel Cook, MS, MD, Dan T. Vogl, MD, Patricia A. Mangan, APRN, BC, Kimberly Hummel, Kathleen Cunningham, Selina Luger, MD, David Porter, MD, Stephen J. Schuster, MD, Una O'Doherty, Mary Sell, Don L. Siegel, MD, PhD, BSc, Edward A. Stadtmauer, MD

Blood (2009) 114 (22): 2146.

https://doi.org/10.1182/blood.V114.22.2146.2146

Published: 2009

Journal Articles

Combined Autophagy and Proteasome Inhibition for Multiple Myeloma: Preliminary Results of a Phase 1/2 Trial of Hydroxychloroquine and Standard Dose Bortezomib for Relapsed or Refractory Myeloma

Dan T. Vogl, Edward A. Stadtmauer, James E. Bradner, Lisa Davis, Martin Carroll, Charles W. Nichols, Doris Shank, Mary Carberry, Cezary R. Swider, Patricia A. Mangan, Brenda K. Shelly, Craig B. Thompson, Ravi K. Amaravadi

Blood (2008) 112 (11): 3684.

https://doi.org/10.1182/blood.V112.11.3684.3684

Published: 2008

Journal Articles

Thalidomide and Dexamethasone Induction Therapy Is Associated with Superior Progression-Free Survival after Autotransplant for Myeloma.

Dan T. Vogl, MD, Selina Luger, MD, David L. Porter, MD, Elise A. Chong, Stephen J. Schuster, MD, Donald E. Tsai, MD, Alexander Perl, MD, Alison W. Loren, MD, MS, Stephen Goldstein, MD, Sunita D. Nasta, MD, Charalambos Andreadis, MD, Patricia A. Mangan, Kimberly Hummel, Donald L. Siegel, MD, PhD, Eli Glatstein, MD, Edward A. Stadtmauer, MD

Blood (2005) 106 (11): 1171.

https://doi.org/10.1182/blood.V106.11.1171.1171

Published: 2005

Journal Articles

Long Term Follow-Up of 4-Hydroperoxycyclophosphamide Purged Autologous Bone Marrow Transplantation in Non-Hodgkin’s Lymphoma Patients with High Risk of Bone Marrow Involvement.

Elise A. Chong, Charalambos Andreadis, MD, Stephen J. Schuster, MD, Selina M. Luger, MD, David L. Porter, MD, Sunita Nasta, MD, Rebecca Elstrom, MD, Steven Goldstein, MD, Robert Sachs, MT, Lisa Downs, CRNP, Joel Green, Patricia A. Mangan, CRNP, Kimberly A. Hummel, Edward A. Stadtmauer, MD

Blood (2004) 104 (11): 5234.

https://doi.org/10.1182/blood.V104.11.5234.5234

Published: 2004

NARROW

Circulating Multiple Myeloma Cells (CMMCs): A Novel Method for Detection and Molecular Characterization of Peripheral Blood Plasma Cells in Multiple Myeloma Precursor States

A Single-Center Retrospective Comparison of Post-Transplant Outcomes in Patients Receiving VRD Vs. VD Vs. RD As Initial Therapy Prior to ASCT for Newly Diagnosed Multiple Myeloma (MM)

Combined Autophagy and Proteasome Inhibition for Multiple Myeloma: Final Results of a Phase 1 Trial of Hydroxychloroquine and Standard Dose Bortezomib for Patients with Relapsed or Refractory Myeloma

Transfer of influenza vaccine–primed costimulated autologous T cells after stem cell transplantation for multiple myeloma leads to reconstitution of influenza immunity: results of a randomized clinical trial

Plerixafor and G-CSF Versus Cyclophosphamide and G-CSF for Stem Cell Mobilization in Patients with Multiple Myeloma.

Combined Autophagy and Proteasome Inhibition for Multiple Myeloma: Preliminary Results of a Phase 1/2 Trial of Hydroxychloroquine and Standard Dose Bortezomib for Relapsed or Refractory Myeloma

Thalidomide and Dexamethasone Induction Therapy Is Associated with Superior Progression-Free Survival after Autotransplant for Myeloma.

Long Term Follow-Up of 4-Hydroperoxycyclophosphamide Purged Autologous Bone Marrow Transplantation in Non-Hodgkin’s Lymphoma Patients with High Risk of Bone Marrow Involvement.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only